SevenBridge Financial Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-820
Closed -$76K 660
2019
Q2
$76K Buy
820
+201
+32% +$19.1K 0.03% 229
2019
Q1
$58K Buy
619
+7
+1% +$612 0.02% 228
2018
Q4
$39K Sell
612
-737
-55% -$54.4K 0.02% 233
2018
Q3
$121K Sell
1,349
-191
-12% -$16.9K 0.06% 160
2018
Q2
$122K Sell
1,540
-322
-17% -$26.7K 0.07% 166
2018
Q1
$166K Sell
1,862
-468
-20% -$44.9K 0.1% 145
2017
Q4
$243K Sell
2,330
-2,563
-52% -$289K 0.13% 125
2017
Q3
$713K Buy
4,893
+1,050
+27% +$143K 0.41% 74
2017
Q2
$499K Buy
3,843
+50
+1% +$6.13K 0.3% 83
2017
Q1
$476K Buy
3,793
+685
+22% +$82K 0.31% 82
2016
Q4
$313K Hold
3,108
0.23% 97
2016
Q3
$313K Sell
3,108
-18
-0.6% -$1.95K 0.23% 97
2016
Q2
$308K Buy
+3,126
New +$323K 0.22% 103

Other funds holding CELG

SevenBridge Financial Group's CELG Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 820 shares — an estimated $76K sold.

SevenBridge Financial Group first reported a position in CELG in Q2 2016 and held it in 13 quarters. The position peaked at $713K in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • SevenBridge Financial Group reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • SevenBridge Financial Group sold 820 Celgene Corp shares in Q3 2019, an estimated $76K.
  • SevenBridge Financial Group first reported a position in Celgene Corp in Q2 2016 and held it in 13 quarters.
  • SevenBridge Financial Group's Celgene Corp position peaked at $713K in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.